KeyBanc lowered the firm’s price target on Teradyne (TER) to $140 from $150 and keeps an Overweight rating on the shares following the company’s analyst day. The firm thinks the risk/reward skews strongly positive from this level, but acknowledges macro conditions could delay an upcycle, and Teradyne’s lack of visibility could lead to more misses relative to its forecasts and consensus estimates.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Teradyne price target lowered to $85 from $100 at BofA
- Teradyne Positioned for Growth Amid Industry Trends and Strategic Acquisitions
- Teradyne’s Revised Guidance and Trade Uncertainties Prompt Sell Rating by Analyst Shane Brett
- Cautious Outlook on Teradyne Amid Macroeconomic Challenges and Ambitious Growth Targets
- Teradyne price target lowered to $120 from $145 at JPMorgan
Questions or Comments about the article? Write to editor@tipranks.com